A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
- 1 March 2015
- journal article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 13 (3), 531-538
- https://doi.org/10.1016/j.cgh.2014.07.055
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative ColitisGastroenterology, 2011
- Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab studyAlimentary Pharmacology & Therapeutics, 2010
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or InfliximabGastroenterology, 2009
- Population pharmacokinetic analysis of infliximab in patients with ulcerative colitisEuropean Journal of Clinical Pharmacology, 2009
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitisGut, 2009
- A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitisAlimentary Pharmacology & Therapeutics, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisThe New England Journal of Medicine, 2005
- High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosisGut, 2001
- Association of Antineutrophil Cytoplasmic Antibodies With Resistance to Treatment of Left-Sided Ulcerative Colitis: Results of a Pilot StudyMayo Clinic Proceedings, 1996
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisThe New England Journal of Medicine, 1987